Sign in

Research summary ·

Primary Hepatic Neuroendocrine Neoplasms: Systematic Review and Expert Pathologist Reappraisal Using the WHO 6th Edition Framework.

Written based on 1 research study on PubMed, searched on 5 Nov 2026.

What was studied

This review looked at primary liver neuroendocrine tumors, which are very rare. Expert pathologists re-checked the published reports. They used the WHO 6th edition framework. Of 67 studies, 28 were kept. These held 57 likely cases, mostly case reports and small case series.

What they found

Most of the 57 cases were well-differentiated neuroendocrine tumors. Poorly differentiated carcinomas, mixed tumors and amphicrine carcinomas were less common. Some high-grade tumors could not be sorted as well or poorly differentiated. The final set held 28 studies.

What it means for patients

The authors said future work should report a minimum set of diagnostic data. This applies to studies and registries. They said terms should be standard, following the WHO 6th edition. They also called for deeper clinical and imaging work.

Why it is not certain yet

These tumors are rare, so the evidence is thin. It is often unclear if a tumor began in the liver. Older reports used mixed terms and may have sorted tumors wrongly. Most cases came from case reports and small case series.

Source

Primary Hepatic Neuroendocrine Neoplasms: Systematic Review and Expert Pathologist Reappraisal Using the WHO 6th Edition Framework.

PubMed · PMID 42870503

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Neuroendocrine tumours publications
Primary Hepatic Neuroendocrine Neoplasms: Systematic Review and Expert Pathologist Reappraisal Using the WHO 6th Edition Framework. · Neuroendocrine tumours news explained – Frontlight Research